Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RCEL · against 398 other Healthcare companies of similar size
Ranked #72 of 399 · scores higher than 81% of peers
Bars: peers in each 10-point band of the growth score41 peers with a growth score of 70–79, including RCEL · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | RCEL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 412 reported | 11.5% | 3.1% | 70% | 33% | |
| Earnings per share growthHigher is better · 203 reported | Not reported | 3.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 391 reported | 27.7% | 3.7% | 89% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 2 | 609M USD | 99 | 91 | |
| 5 | 3.9B HKD (≈$493M) | 98 | 66 | |
| 66 | 646M USD | 79 | 46 | |
| 72 | 457M USD | 78 | 58 | |
| 72 | 326M EUR (≈$359M) | 78 | 75 | |
| 72 | 549M EUR (≈$604M) | 78 | 56 | |
| 72 | 474M USD | 78 | 25 | |
| 76 | 3.4B CNY (≈$480M) | 77 | 74 | |
| 76 | 301M USD | 77 | 67 | |
| 76 | 487M USD | 77 | 29 | |
| 76 | 468M EUR (≈$514M) | 77 | 57 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score